Barbara-Jean Anne Bormann-Kennedy
Director · 1 filing · Latest: Jun 4, 2026
Xeris Biopharma Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XERS | Barbara-Jean Anne Bormann-Kennedy | Director | Jun 4, 2026 | Sale | $6.09 | 16,000 | $97.5K | 126,500 | |
XERS | Barbara-Jean Bormann-Kennedy | — | Jun 4, 2026 | Proposed Sale | $5.89 | 16,000 | $94.2K | — | |
XERS | BARBARA-JEAN A BORMANN-KENNEDY | — | Dec 12, 2025 | Proposed Sale | $7.01 | 15,000 | $105.2K | — |